Harfst & Associates’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4M Buy
22,702
+29
+0.1% +$4.18K 0.62% 26
2026
Q1
$2.86M Buy
22,673
+881
+4% +$124K 0.51% 31
2025
Q4
$2.94M Sell
21,792
-982
-4% -$131K 0.53% 29
2025
Q3
$2.82M Sell
22,774
-202
-0.9% -$22.2K 0.52% 31
2025
Q2
$2.27M Buy
22,976
+7,242
+46% +$592K 0.47% 36
2025
Q1
$1.03M Buy
+15,734
New +$1.07M 0.24% 49

Other funds holding APH

Harfst & Associates's APH Position: Q2 2026 in Review

Harfst & Associates increased its Amphenol (APH) stake by 0.13% in Q2 2026, buying an estimated $4.18K and bringing the position to 22,702 shares worth $4M. The position accounts for 0.62% of the portfolio, ranked #26.

Harfst & Associates first reported a position in APH in Q1 2025 and has held it in 6 quarters since. 2,323 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Harfst & Associates held 22,702 shares of Amphenol worth $4M as of Q2 2026.
  • Harfst & Associates bought 29 Amphenol shares in Q2 2026, an estimated $4.18K.
  • Amphenol made up 0.62% of Harfst & Associates's portfolio in Q2 2026, its #26 holding.
  • Harfst & Associates first reported a position in Amphenol in Q1 2025 and has held it in 6 quarters since.
  • 2,323 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Harfst & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.